Skip to main content
. Author manuscript; available in PMC: 2023 Jan 3.
Published in final edited form as: J Neuroimmunol. 2021 Sep 15;360:577721. doi: 10.1016/j.jneuroim.2021.577721

Table 3a.

Distribution of EDSS scores in PML patients based on mortality outcomes.

Non-fatal cases (n = 189)
Fatal cases (n = 25)
Wilcoxon Rank Sum test (p value)
Mean (SD) Total Mean (SD) Total
EDSS following management PML 5.48 (2.29) 189 10 (0) 25 <0.001
EDSS at PML diagnosis 4.92 (1.93) 189 5.32 (2.07) 25 0.55
Change in EDSS at baseline and Post PML treatment 2.33 (1.4) 143 4.5 (1.95) 15 <0.001
Change in EDSS at PML diagnosis and post PML treatment 0.56 (1.47) 189 4.54 (2.19) 25 <0.001

Abbreviations: EDSS - Expanded disability status scale, PML - Progressive Multifocal Leukoencephalopathy.